Catalyst Pharmaceuticals Inc CPRX shares are trading lower by 13% to $14.89 Friday morning. The company announced the pricing of a public offering of 10 million shares of its common stock at $15.00 per share, resulting in total gross proceeds of $150 million.
The underwriters have a 30-day option to purchase an additional 1.5 million shares. The offering, expected to close around January 9 is led by bookrunners BofA Securities, Citigroup, Piper Sandler & Co., Cantor and Truist Securities.
Catalyst intends to use the net proceeds for potential new product candidate acquisitions and general corporate purposes.
See Also: December Jobs Report Topples Expectations
According to data from Benzinga Pro, CPRX has a 52-week high of $22.11 and a 52-week low of $11.09.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
